This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Dec 20;23(36):9427; author reply 9428.

doi: 10.1200/JCO.2005.03.6970.

Calculation of survival of patients with stage III melanoma

David Berd, Michael J Mastrangelo, Takami Sato

PMID: 16361644
DOI: 10.1200/JCO.2005.03.6970

Comment

Calculation of survival of patients with stage III melanoma

David Berd et al. J Clin Oncol. 2005.

. 2005 Dec 20;23(36):9427; author reply 9428.

doi: 10.1200/JCO.2005.03.6970.

Authors

David Berd, Michael J Mastrangelo, Takami Sato

PMID: 16361644
DOI: 10.1200/JCO.2005.03.6970

No abstract available

PubMed Disclaimer

Comment on

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A. Balch CM, et al. J Clin Oncol. 2001 Aug 15;19(16):3622-34. doi: 10.1200/JCO.2001.19.16.3622. J Clin Oncol. 2001. PMID: 11504744

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information